Exosome Diagnostics, Inc.: Clinical Trials

10 trials sponsored by Exosome Diagnostics, Inc., newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown, 3 completed, 1 active not recruiting, 1 suspended. 1 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable1Unknown 1

Follow Exosome Diagnostics, Inc.: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
ExoDx Prostate Evaluation in Active Surveillance Patient Population
ExoDx Prostate - Prostate Cancer
UnknownExosome Diagnostics, Inc.7502022-10-012022-10-07
Urine Biomarker for Kidney Transplant Rejection
Urine Biomarker for Kidney Transplant Rejection - Graft Rejection
UnknownExosome Diagnostics, Inc.7502021-10-012021-10-11
Clinical Evaluation of ExoDx Prostate(IntelliScore) in Men Presenting for Initial Prostate Biopsy
ExoDx Prostate(IntelliScore) - Urologic Cancer
CompletedExosome Diagnostics, Inc.1202020-06-012021-09-30
ExoDx Prostate Evaluation in Prior Negative Prostate Biopsy Setting
ExoDx Prostate - Prostate Cancer
TerminatedExosome Diagnostics, Inc.1502020-03-152022-03-31
Decision Impact Trial of the ExoDx Prostate (IntelliScore)
ExoDx Prostate (IntelliScore) - Cancer of the Prostate
Not applicableUnknownExosome Diagnostics, Inc.10002017-07-192022-05-06
Clinical Evaluation of the 'ExoDx Prostate IntelliScore' (EPI)
ExoDx Prostate Intelliscore - Cancer of Prostate
CompletedExosome Diagnostics, Inc.5322016-09-012020-12-29
Detection of ARv7 in the Plasma of Men With Advanced Metastatic Castrate Resistant Prostate Cancer (MCRP)
Metastatic Castrate Resistant Prostate Cancer
SuspendedExosome Diagnostics, Inc.302016-02-012022-10-06
Detection of Either the EML4-ALK Gene Rearrangements or the T790M EGFR Mutation in the Plasma of Advanced NSCLC Patients
Carcinoma, Non-Small-Cell Lung
UnknownExosome Diagnostics, Inc.602015-03-012021-09-30
Clinical Validation of a Urinary Exosome Gene Signature in Men Presenting for Suspicion of Prostate Cancer
ExoIntelliScore Prostate - Prostate Cancer
CompletedExosome Diagnostics, Inc.20002014-05-012016-03-09
Molecular Studies and Clinical Correlations in Human Prostatic Disease
Prostate Cancer
Active not recruitingMemorial Sloan Kettering Cancer Center52901990-04-012026-03-09

Conditions studied

Prostatic Neoplasms (6)  ·  Carcinoma, Non-Small-Cell Lung (1)  ·  Urologic Neoplasms (1)

Countries

United States (8)  ·  Germany (1)

Top investigators

Roger Tun (5)  ·  Mikkel Noerholm (1)  ·  Ronald F Tutrone, MD (1)  ·  Sonia Kumar (1)  ·  Sonia Kumar, PhD (1)  ·  Susan Slovin, MD (1)

Results publications

PMID 35084544, PMID 26345389, PMID 30237023, PMID 32382078, PMID 35314720, PMID 37193776